Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
Glaxo Teams with Texas A&M for Influenza Manufacturing Center of Excellence Industry News April 5, 2013 …
Study of Virus-Killing Bacteria Motion Advances Nanotechnology Medical Countermeasures April 1, 2013 …
U.S. Army Hantavirus Vaccine Support Contract to Althea Technologies Defense + Military April 1, 2013 …
Government Building ‘Fill and Finish’ Network for Pandemic Influenza Vaccines Contracts + Grants April 1, 2013 …
Drug Target Development Proposals Sought for Antimicrobial-Resistant Pathogens Antimicrobial Resistance March 27, 2013 …
Study Reveals Potential Treatments for Ebola and Other Deadly Viruses Medical Countermeasures March 26, 2013 …
USF Researchers Play Key Role in Discovery of New Drug to Combat Malaria Medical Countermeasures March 25, 2013 …
FDA Approves First Antitoxin to Neutralize All 7 Botulism Serotypes Medical Countermeasures March 25, 2013 …
Nanotherapeutics Awarded $135M for Medical Countermeasures Advanced Development Defense + Military March 23, 2013 …
Anthrax Vaccine Trial for Kids? The Ethics of Pediatric Countermeasures Research Medical Countermeasures March 19, 2013 …
